A pharmacy chain built by two pharmacists from a single outlet in Damansara Uptown in 2006 now stands at the threshold of public ownership, pricing its shares at RM1.08 in a bid to raise RM2.03 billion. Much of what it gathers will not expand the business but repay the debt that its own acquisitions left behind, a quiet reminder that growth is often financed by borrowing before it is rewarded by the market. As the offer moves toward its November listing, the question is less about the headline sum than about whether the promise of an aging, health-conscious society can justify a valuation near
Big Caring Prices Main Market IPO at RM1.08 a Share, Targeting RM2 Billion Raise
Most of the money goes to sellers; most of the company's share goes to lenders
Why does this listing stand out beyond its size?
It's the second-largest in Malaysia this year at RM2.03 billion, and it comes from a chain that began as one shop in Damansara Uptown in 2006 and now has 668 outlets.
Most of the money isn't going to the company, is it?
Right. The company gets RM637.8 million, while selling shareholders, including the founders and Creador, take RM1.4 billion.
Worth noting that selling down is common in IPOs, but the source doesn't say how much of their stakes they're selling, only that it's part.
And the company's share goes mostly to debt?
Ninety percent, against RM1.7 billion in borrowings as of end-August, largely from buying Caring Pharmacy from 7-Eleven Malaysia, Medispec and a stake in Your Physio.
Ninety percent of RM637.8 million won't clear RM1.7 billion, though. The reporting doesn't say what the debt looks like afterward.
What about the 42 times earnings?
It's rich, but profit rose over 62% to RM231.8 million and revenue grew over 18% to RM4 billion.
Whether 42 times is justified is a judgment, not a fact in this piece. The growth figures are company-reported, and nothing here tells us how analysts see it.
So what do we watch?
Applications close Nov 5, listing is Nov 19, and then the debt paydown.
Le Pouls
- A RM1.08 price tag puts an expansive pharmacy network of 668 outlets under the scrutiny of public investors for the first time.
- Most of the fresh cash of RM637.8 million is being steered straight toward lenders, with RM1.7 billion in bank borrowings still weighing on the balance sheet.
- Founders and private equity holders are cashing out RM1.4 billion, a split that invites buyers to ask how much confidence sellers truly carry.
- Cornerstone commitments from Aberdeen, AHAM and the IFC are laying a steadying foundation before the wider market takes its position.
- Applications close on November 5 and listing follows on November 19, with the valuation and the pace of debt reduction set to decide how the story lands.
A pharmacy chain built by two pharmacists from a single outlet in Damansara Uptown in 2006 now stands at the threshold of public ownership, pricing its shares at RM1.08 in a bid to raise RM2.03 billion. Much of what it gathers will not expand the business but repay the debt that its own acquisitions left behind, a quiet reminder that growth is often financed by borrowing before it is rewarded by the market. As the offer moves toward its November listing, the question is less about the headline sum than about whether the promise of an aging, health-conscious society can justify a valuation near 42 times earnings.
Big Caring Group, the company behind the BIG Pharmacy and CARiNG Pharmacy chains, has priced its Main Market initial public offering at RM1.08 a share, seeking RM2.03 billion. If completed, it would be Malaysia's second-largest listing this year, a sign of how far the business has travelled since its beginnings.
The proceeds tell two stories at once. The company will keep RM637.8 million of fresh capital, while existing shareholders, including the founders and the private equity firm Creador, will collect RM1.4 billion from their stakes. Most of the company's share goes to lenders, who are owed RM1.7 billion, much of it borrowed to buy Caring Pharmacy, Medispec and Your Physio.
The founders, Lee Meng Chuan and Lim Sin Yin, both trained pharmacists, opened their first outlet in Damansara Uptown in 2006. Today the group runs 668 outlets under several brands and holds a 24.2% market share. Lee credits changing demographics, rising health awareness and demand for accessible care for the momentum behind its net profit, which rose more than 62% to RM231.8 million in the year to June 2026.
Cornerstone investors Aberdeen, AHAM and the International Finance Corporation have committed ahead of the public offer, giving the deal a steadier footing. Applications close on November 5 and listing is set for November 19. What comes next will show whether investors accept a valuation near 42 times earnings, and how quickly the debt begins to shrink.
Big Caring Group Bhd, the operator behind the BIG Pharmacy and CARiNG Pharmacy chains, has set the price of its Main Market initial public offering at RM1.08 a share, aiming to raise RM2.03 billion. That would make it Malaysia's second-largest listing this year, according to its prospectus.
The money is split unevenly. The company itself will receive RM637.8 million in fresh proceeds, while a group of selling shareholders will collectively take in RM1.4 billion. More than a dozen existing shareholders are selling part of their stakes through an offer for sale, among them Lee Meng Chuan and Lim Sin Yin through their joint vehicle, and the private equity firm Creador.
Most of what the company receives will go to its lenders. Big Caring plans to put 90% of the primary proceeds toward trimming bank borrowings, which stood at RM1.7 billion on its balance sheet at the end of August. The bulk of that debt came from acquisitions: RM888.3 million to buy Caring Pharmacy from 7-Eleven Malaysia Holdings Bhd in 2023, RM249.4 million for the pharmaceutical distributor Medispec, and RM32.8 million for a controlling stake in the physiotherapy chain Your Physio. A further RM30 million is set aside for a new distribution centre in Klang to strengthen the nationwide logistics network, and RM37.1 million will cover listing expenses.
At RM1.08, the company would carry a market capitalisation of RM8 billion, or about 42 times its trailing earnings at listing. The recent results are strong: for the financial year ended June 30, 2026, net profit rose more than 62% to RM231.8 million, and revenue grew over 18% to RM4 billion.
Lee, the managing director, pointed to the forces behind that growth when the prospectus was launched on Thursday. Changing demographics, greater health awareness and demand for accessible healthcare, he said, continue to drive the industry.
The company's origins are modest by comparison. Lee and Lim, who is an executive director, are both trained pharmacists, and they opened their first retail outlet in Damansara Uptown in 2006. Big Caring now has 668 outlets nationwide under several brands, including Georgetown Pharmacy, Wellings, Ting Pharmacy and iCare Pharmacy alongside the two flagship names. As of the end of September it held a 24.2% market share.
The offering has cornerstone investors lined up: the fund managers Aberdeen Group plc and AHAM Asset Management, and the International Finance Corporation, the World Bank's private-sector arm. Cornerstone investors commit to taking a portion of shares before the wider marketing begins, which tends to reassure other buyers.
Maybank Investment Bank and RHB Investment Bank are joint principal advisers, global coordinators, bookrunners, managing underwriters and underwriters. AmInvestment Bank holds the same roles apart from managing underwriter, and UBS serves as joint global coordinator and bookrunner.
Applications for the IPO close on Nov 5, with listing scheduled for Nov 19. Afterward, the things to watch are how the market treats a valuation near 42 times earnings, and how quickly the debt comes down.
Citations marquantes
Changing demographics, greater health awareness and demand for accessible healthcare continue to drive growth in our industry.— Lee Meng Chuan, managing director, Big Caring Group